Piper Sandler Q1 Record Revenues Fueled by Debt Capital Markets and Healthcare ECM Gains
PIPR•Piper Sandler posted record Q1 revenues led by its Debt Capital Markets advisory and a high volume of small bank M&A closings despite softer large-deal activity. Healthcare equity capital markets delivered outsized market share gains, though management cautioned against sustaining first-quarter levels, and sequential advisory fees are forecast lower.
1. Q1 Record Revenues and Debt Capital Markets Performance
Piper Sandler posted record Q1 revenues driven by an outstanding performance in its Debt Capital Markets advisory unit, which saw activity surge during the quarter. The desk benefited from both higher structuring fees and increased derivative transactions completed for institutional clients.
2. Bank M&A Activity Trends
The firm closed a significant number of small bank M&A transactions in Q1 but noted a slowdown in larger megadeals. Its derivatives desk reported robust client engagement, with a rise in completed hedging transactions reflecting recent rate volatility.
3. Healthcare Equity Capital Markets Share
Piper Sandler achieved outsized market share gains in healthcare equity capital markets, securing several high-fee biotech and MedTech offerings. Management cautioned that this elevated share level is unlikely to be maintained through Q2 given expected market normalization.
4. Advisory Outlook and Non-M&A Growth
Advisory fees are projected to decline sequentially due to choppy macro conditions, particularly in bank M&A. Non-M&A divisions saw mixed results: restructuring and private capital advisory remained stable, while Debt Capital Markets drove the quarter’s standout performance.
